| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.08 | 0.1 |